ESR1 and breast carcinoma: In estrogen receptor-positive breast cancer cells, MTA1 suppresses the estrogen-receptor element-driven transcription and disrupts estradiol responsiveness, thus contributing to progression of breast cancer to more invasive phenotypes [7].